---
title: “Studies Demonstrate Use of Gentian Calprotectin Test to Triage COVID-19 Patients”
description: Studies suggests that plasma/serum calprotectin can be a valuable biomarker for prediction of mortality and need for mechanical ventilation.
---

[Gentian News | Company | Products | Employees | Blog ](https://www.gentian.com/news)

# [“Studies Demonstrate Use of Gentian Calprotectin Test to Triage COVID-19 Patients”](https://www.gentian.com/news/calprotectin-test-triage-covid19-patients)

 Written by [Kristin Hart](https://www.gentian.com/news/author/kristin-hart) | Jan 28, 2021 9:31:23 AM

Gentian has together with research partners presented [two posters related to the ](https://www.gentian.com/news/the-value-of-calprotectin-in-covid-19-highlighted-at-aacc-2020)[value of plasma and serum calprotectin in the management of COVID-19 patients at the AACC 2020](https://www.gentian.com/news/the-value-of-calprotectin-in-covid-19-highlighted-at-aacc-2020). The results presented at the AACC conference show elevated levels of calprotectin in plasma/serum in patients with severe form of COVID-19. This suggests that calprotectin can be a valuable biomarker for prediction of mortality and need for mechanical ventilation. Both studies have used [Gentian’s calprotectin immunoassay GCAL®](https://www.gentian.com/clinical-diagnostic-products/plasma-serum-calprotectin-immunoassay/) for measurement of calprotectin in plasma and serum.

 

## GCAL® to triage COVID-19 patients and PETIA benefits

[360Dx](https://www.360dx.com/), a dedicated newsroom that covers emerging economic and technological trends in the clinical diagnostic market, has caught interest in the utility of calprotectin as a tool for risk assessment and prediction of clinical deterioration in COVID-19 patients.

360Dx has recently published an article that focuses on the recent results from the two AACC posters, confirming the value of calprotectin in severe COVID-19 disease. In the same article they also emphasises GCAL® 's (Gentian’s plasma and serum calprotectin assay) advantages being a [particle-enhanced turbidimetric immunoassay](https://www.gentian.com/news/petia) (PETIA), compared to conventional enzyme-linked immunosorbent assays (ELISA).

Read the full article [Studies Demonstrate Use of Gentian Calprotectin Test to Triage COVID-19 Patients](https://www.gentian.com/hubfs/Studies%20Demonstrate%20Use%20of%20Gentian%20Calprotectin%20Test%20to%20Triage%20COVID-19%20Patients-%20Reprint.pdf) with information from the two poster and more insights from Gentian's VP Clinical Affairs, Dr. Aleksandra Mandic Havelka and one of the co-author of one of the posters Dr. Luis García de Guadiana-Romualdo from the [Hospital Universitario Santa Lucía](https://www.murciasalud.es/seccion.php?idsec=4614#) in Cartagena, Spain.

 

 

## Contact us for more information

Do you want to know more about our calprotectin and COVID-19 or our GCAL®  Immunoassay? If yes, please fill out the form below or send an email to [marketing@gentian.com ](mailto:marketing@gentian.com)and our Product Manager for GCAL® will contact you shortly.

 

[View full post](https://www.gentian.com/news/calprotectin-test-triage-covid19-patients)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Kristin Hart"
  },
  "dateModified" : "2021-06-08T08:46:46.004Z",
  "datePublished" : "2021-01-28T09:31:23Z",
  "headline" : "“Studies Demonstrate Use of Gentian Calprotectin Test to Triage COVID-19 Patients”",
  "image" : {
    "@type" : "ImageObject",
    "height" : 500,
    "url" : "https://f.hubspotusercontent40.net/hubfs/6752890/360Dx_web-ready2.jpg",
    "width" : 1000
  },
  "mainEntityOfPage" : "https://www.gentian.com/news/calprotectin-test-triage-covid19-patients",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "News"
  }
}
```